These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37989489)

  • 1. Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study.
    Lin SJ; Liao XM; Chen NY; Chang YC; Cheng CL
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37989489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
    Dong YH; Chang CH; Wu LC; Lai MS
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
    Atzema CL; Austin PC
    Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Romiti GF; Corica B; Pipitone E; Vitolo M; Raparelli V; Basili S; Boriani G; Harari S; Lip GYH; Proietti M;
    Eur Heart J; 2021 Sep; 42(35):3541-3554. PubMed ID: 34333599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease.
    You SC; An MH; Yoon D; Ban GY; Yang PS; Yu HT; Park RW; Joung B
    Heart Rhythm; 2018 Dec; 15(12):1825-1832. PubMed ID: 30509364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
    Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
    BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.
    Scheuermeyer FX; Grafstein E; Stenstrom R; Christenson J; Heslop C; Heilbron B; McGrath L; Innes G
    Acad Emerg Med; 2013 Mar; 20(3):222-30. PubMed ID: 23517253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
    Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
    PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study).
    Su VY; Ko SW; Chang YL; Chou YC; Lee HC; Yang KY; Chou KT; Hsu CC
    Allergy Asthma Immunol Res; 2022 May; 14(3):314-327. PubMed ID: 35557496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
    Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative persistence on β-blockers versus calcium channel blockers for ventricular rate control in nonelderly patients with atrial fibrillation.
    Desai VC; Kelton CM; Metzger AH; Cavanaugh TM; Guo JJ; Heaton PC
    Ann Pharmacother; 2014 Dec; 48(12):1570-9. PubMed ID: 25280975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease and the development of atrial fibrillation.
    Grymonprez M; Vakaet V; Kavousi M; Stricker BH; Ikram MA; Heeringa J; Franco OH; Brusselle GG; Lahousse L
    Int J Cardiol; 2019 Feb; 276():118-124. PubMed ID: 30268382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.